Product NDC: | 0067-2037 |
Proprietary Name: | EXCEDRIN |
Non Proprietary Name: | Acetaminophen, Aspirin and Caffeine |
Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin and Caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0067-2037 |
Labeler Name: | Novartis Consumer Health, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | NDA020802 |
Marketing Category: | NDA |
Start Marketing Date: | 20100215 |
Package NDC: | 0067-2037-84 |
Package Description: | 125 TABLET, FILM COATED in 1 BOTTLE (0067-2037-84) |
NDC Code | 0067-2037-84 |
Proprietary Name | EXCEDRIN |
Package Description | 125 TABLET, FILM COATED in 1 BOTTLE (0067-2037-84) |
Product NDC | 0067-2037 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Aspirin and Caffeine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20100215 |
Marketing Category Name | NDA |
Labeler Name | Novartis Consumer Health, Inc. |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Strength Number | 250; 250; 65 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |